Cholangiocarcinoma

The Pharmacy Times® Cholangiocarcinoma Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of cholangiocarcinoma.

Latest News

3d illustration proteins with lymphocytes t cells or cancer cells | Image Credit: Design Cells - stock.adobe.com
Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years

April 18th 2024

The results were the longest survival follow-up ever reported for a phase 3 trial for biliary tract cancer.

Medical conference panel
Pharmacists Can Help Address Treatment Challenges for Patients With Cholangiocarcinoma

December 19th 2023

Chalk drawing of human liver with medical term. Concept of learning medicine.
New FGFR Inhibition Therapies Show Promise in Intrahepatic Cholangiocarcinoma

June 4th 2023

Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer
Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer

January 26th 2023

Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRI
Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRI

January 9th 2023

Latest CME Events & Activities

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

<12
© 2024 MJH Life Sciences

All rights reserved.